🟢 HCWB is trading 55% up today after a $4M private placement and promising preclinical data

HCWB is trading 55% up at $4.01 in pre-market trading, extending a significant two-day rally following key corporate updates.

• The company secured a $4.0 million private placement with healthcare investors to fund clinical programs and IND-enabling work for its T-cell engager HCW11-018b and checkpoint inhibitor HCW11-040.
• Investor sentiment is further bolstered by promising preclinical data for HCW11-018b, with momentum trading contributing to the stock's recent multi-day gains.